Stock 239 PAK FAH YEOW INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Pak Fah Yeow International Limited

Equities

239

BMG6873Y1176

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:09 2024-04-25 am EDT 		5-day change 1st Jan Change
2.07 HKD +2.99% Intraday chart for Pak Fah Yeow International Limited +0.98% +16.95%
Mar. 26 Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 08 Pak Fah Yeow International Forecasts Attributable Profit to Triple in 2023 MT

Business Summary

Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

Number of employees: 102

Sales per Business

HKD in Million2022Weight2023Weight Delta
Healthcare
94.6 %
139 94.7 % 245 94.6 % +75.81%
Property Investments
3.7 %
7 4.8 % 10 3.7 % +34.77%
Treasury Investments
1.7 %
1 0.4 % 4 1.7 % +611.20%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
81.1 %
106 71.8 % 210 81.1 % +98.92%
Southeast Asia
13.5 %
27 18.1 % 35 13.5 % +31.48%
North America
2.8 %
10 7.0 % 7 2.8 % -29.58%
United Kingdom
2.1 %
3 2.1 % 6 2.1 % +76.87%
Other Regions
0.4 %
1 0.9 % 1 0.4 % -22.07%

Managers

Managers TitleAgeSince
Wee Sean Gan CEO
 Chief Executive Officer 77 91-10-07
Hung Kei Tsang DFI
 Director of Finance/CFO 53 05-04-30
Fock Wai Gan BRD
 Director/Board Member 62 -
Tai On Lo SEC
 Corporate Secretary 69 09-01-18

Members of the board

Members of the board TitleAgeSince
Fock Wai Gan BRD
 Director/Board Member 62 -
Man Chiu Leung BRD
 Director/Board Member 75 06-06-30
Wee Sean Gan CEO
 Chief Executive Officer 77 91-10-07
Cheng Hooi Gan BRD
 Director/Board Member 43 -
Fook Yin Gan BRD
 Director/Board Member 55 15-09-22
Chi Chung Chan BRD
 Director/Board Member 46 22-09-29
Renato Dell’Orto BRD
 Director/Board Member 71 22-09-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 311,640,000 120,012,599 ( 38.51 %) 0 38.51 %

Shareholders

NameEquities%Valuation
Gan's Enterprises Ltd.
20.06 %
62,527,920 20.06 % 17 M $
Fock Wai Gan
3.448 %
10,746,879 3.448 % 3 M $

Company contact information

Pak Fah Yeow International Ltd.

200 Gloucester Road 11th Floor, Wan Chai

, Hong Kong

+

http://www.pakfahyeow.com
address Pak Fah Yeow International Limited(239)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
PAK FAH YEOW INTERNATIONAL LIMITED Stock Pak Fah Yeow International Limited
+16.95% 79.97M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.49% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 239 Stock
  4. Company Pak Fah Yeow International Limited